Document Actions
Doctors
Up one levelLoading in progress...
The non-invasive tests,
alternative to liver biopsy
BioPredictive markets non-invasive tests (blood test) for a diagnosis and prognosis of liver diseases.
 For hepatitis B and hepatitis C |
 For hepatitis, alcohol and metabolism |
-
For hepatitis B: FibroTest
For hepatitis B, the test assesses liver fibrosis but also necroinflammatory activity:
-
FibroTestF=0.24 (F1)
Minimal fibrosisEstimates liver fibrosisFibroTest -
ActiTestA=0.48 (A1)
Moderate activityEstimates the necroinflammatory activityActiTest
-
-
For hepatitis C: FibroTest
For hepatitis C, the test assesses liver fibrosis but also necroinflammatory activity:
-
FibroTestF=0.24 (F1)
Minimal fibrosisEstimates liver fibrosisFibroTest -
ActiTestA=0.48 (A1)
Moderate activityEstimates the necroinflammatory activityActiTest
-
-
Alcohol: FibroMax
For the excessive consumption of alcohol: FibroMax is an appropriate combination of our tests which assesses not only fibrosis (FibroTest) but also steatosis (SteatoTest, estimation of the fatty liver) and steatohepatitis (AshTest, estimation of acute alcoholic hepatitis):
-
FibroTestF=0.24 (F1)
Minimal fibrosisEstimates liver fibrosisFibroTest -
SteatoTestS=0.48 (S1)
Minimal steatosisEstimates the steatohepatitis of the liverSteatoTest -
AshTestH=0.48 (H1)
Minimal ASHEstimates alcoholic steatohepatitis of the liverAshTest
-
-
Metabolic: FibroMax
For the metabolic diseases (overweight, diabetes, hypertriglyceridemia, hypercholesterolemia, hypertension): FibroMax is an appropriate combination of our tests which assesses not only fibrosis (FibroTest) but also steatosis (SteatoTest, estimation of the fatty liver) and steatohepatitis (NashTest, estimation of non-alcoholic steatohepatitis):
-
FibroTestF=0.24 (F1)
Minimal fibrosisEstimates liver fibrosisFibroTest -
SteatoTestS=0.48 (S1)
Minimal steatosisEstimates the steatohepatitis of the liverSteatoTest -
NashTestN=No-Nash (N0)
No NASHEstimates non-alcoholic steatohepatitis of the liverNashTest
-
BioPredictive provides a group of services based on its diagnosis and prognosis products.
In addition to the test calculations, you have access to our expertise to assist you in your daily practice:
Research and development
BioPredictive is an innovative company in which the R&D team has published its work for 20 years.
Our publications
Find all the literature and all the studies concerning Fibrotest or FibroMax
Scientific brochure
The scientific brochure compiles all the scientific information about the BioPredictive tests.
Participating in a clinical study
Do you want to use our tests for a clinical study? Let's talk about it together.
Precautions for use
All of the conditions of use of our diagnostic tests